Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
25.3051
42.6132
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Zhejiang Gongdong Medical Technology Co Ltd
Zhejiang Gongdong Medical Technology Co Ltd
Cash & Cash Equivalents
Zhejiang Gongdong Medical Technology Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
|
Cash & Cash Equivalents
¥397.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Cash & Cash Equivalents
¥7.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Cash & Cash Equivalents
¥349.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Cash & Cash Equivalents
¥4.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
66%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Cash & Cash Equivalents
¥1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Cash & Cash Equivalents
¥6.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Zhejiang Gongdong Medical Technology Co Ltd
Glance View
Zhejiang Gongdong Medical Technology Co., Ltd. engages in the development and production of disposable medical devices and medical inspection supplies. The company is headquartered in Taizhou, Zhejiang and currently employs 1,348 full-time employees. The company went IPO on 2020-09-16. The firm's main products cover vacuum blood collection systems, laboratory testing consumables, body fluid collection consumables, medical care consumables and pharmaceutical packaging materials. Its products include disposable vacuum blood collection tubes, petri dishes, culture plates, cuvettes, pipette tips, disposable sterile sampling swabs, dispensers, dressing containers and others. The firm's products are applied in clinical diagnosis and nursing, scientific research and testing, pharmaceutical packaging and other fields. The firm distributes its products in the domestic market and to overseas markets, including many countries in North America, Asia, South America, Africa and Europe.
See Also
What is Zhejiang Gongdong Medical Technology Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
397.7m
CNY
Based on the financial report for Dec 31, 2023, Zhejiang Gongdong Medical Technology Co Ltd's Cash & Cash Equivalents amounts to 397.7m CNY.
What is Zhejiang Gongdong Medical Technology Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
16%
Over the last year, the Cash & Cash Equivalents growth was -43%. The average annual Cash & Cash Equivalents growth rates for Zhejiang Gongdong Medical Technology Co Ltd have been -20% over the past three years , 16% over the past five years .
You don't have any saved screeners yet
